Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
8,896,104
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
396,349
-
Shares change
-
+283,587
-
Total reported value, excl. options
-
$1,721,000
-
Value change
-
+$1,231,999
-
Number of buys
-
7
-
Price
-
$4.35
Significant Holders of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) as of Q4 2021
8 filings reported holding BRTX - BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value as of Q4 2021.
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 396,349 shares
of 8,896,104 outstanding shares and own 4.46% of the company stock.
Largest 9 shareholders include VANGUARD GROUP INC (152,454 shares), Ayrton Capital LLC (112,762 shares), BOOTHBAY FUND MANAGEMENT, LLC (63,984 shares), Wealth Alliance (40,000 shares), StoneX Group Inc. (14,954 shares), SABBY MANAGEMENT, LLC (10,000 shares), Steward Partners Investment Advisory, LLC (2,001 shares), ADVISOR GROUP HOLDINGS, INC. (194 shares), and UBS Group AG (303 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.